2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice

MASATOSHI MINAMISAWA, TOSHIHISA ANZAI, TAKAYUKI INOMATA, KOICHIRO KINUGAWA, YASUSHI SAKATA, NAOKI SATO, HIROYUKI TSUTSUI, KAZUHIRO YAMAMOTO, MICHIHIRO YOSHIMURA, YOSHIHIKO SAITO, KOICHIRO KUWAHARA*

*この論文の責任著者

研究成果: ジャーナルへの寄稿総説査読

抄録

This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).

本文言語英語
ジャーナルJournal of Cardiac Failure
DOI
出版ステータス受理済み/印刷中 - 2025

ASJC Scopus 主題領域

  • 循環器および心血管医学

フィンガープリント

「2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル